title: [Effect of ligustrazine on the expression of bFGF in bone marrow stromal cells of mice after BMT].
abstract: This study was purposed to investigate the effect of ligustrazine on the expression of bFGF in bone marrow stromal cells (BMSC) and to explore the mechanism of hematopoietic reconstitution after bone marrow transplantation (BMT). The mice were randomly divided into 3 groups: normal group, saline group and ligustrazine group. BMT mouse models were established. The mice of normal group were not treated, the mice of saline group were given normal saline (0.2 ml/mouse, twice a day) through gastric tube, while the mice of ligustrazine group were given ligustrazine (0.2 ml/mouse, twice a day) through gastric tube. On day 7, 14, 21 and 28 after BMT, the femora were taken and the bone marrow mononuclear cell (BMMNC) suspensions were used for the cultivation of bone marrow stromal cells according to Dexter's culture method. The mRNA and protein expressions of bFGF in BMSC were assayed by RT-PCR and Western blot respectively. The results showed that the expression of bFGF in BMSC on the level of mRNA and protein were all reduced significantly after BMT, and increased slowly with the time. On day 7, 14 and 21 after BMT, the expressions of bFGF mRNA and protein in bone marrow stromal cells of ligustrazine group and saline group were lower than that in bone marrow stromal cells of normal group, but the expressions of bFGF mRNA and protein in ligustrazine group were obviously higher than that in saline group (P < 0.01 or P < 0.05). On day 28 after BMT, the expressions of bFGF mRNA and protein in ligustrazine group returned to normal level, while the expressions of bFGF mRNA and protein in saline group not returned to normal level, there was significant difference between these two groups. It is concluded that ligustrazine can enhance bFGF expression level in bone marrow stromal cells after syngeneic bone marrow transplantation in mice, which confirms that ligustrazine can enhance the repair of bone marrow microvessels, improve bone marrow microenvironment and promote hematopoietic reconstitution.
authors.affiliation: Department of Radiation Oncology, Shandong Tumor Hospital and Institute of Oncology, Jinan 250117, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Wu
authors.forename: Deng-Feng
authors.initials: DF
authors.lastname: Zhou
authors.forename: Jie-Lin
authors.initials: JL
authors.lastname: Qi
authors.forename: Xi-Qin
authors.initials: XQ
authors.lastname: Zhang
authors.forename: Bing
authors.initials: B
authors.lastname: Bu
authors.forename: Pu-Xia
authors.initials: PX
authors.lastname: Liu
authors.forename: Ming-Yu
authors.initials: MY
authors.lastname: Wang
authors.forename: Han-Ying
authors.initials: HY
authors.lastname: Sun
authors.forename: Wei-Li
authors.initials: WL
authors.lastname: Liu
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000378:metabolism*; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000096:biosynthesis* / Q000235:genetics; D006410:Hematopoiesis / Q000187:drug effects; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011719:Pyrazines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D011897:Random Allocation; D017154:Stromal Cells / Q000378:metabolism*
chemical_list: D011719:Pyrazines; D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2; C017953:tetramethylpyrazine